Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
44.51
-1.07 (-2.35%)
At close: Oct 21, 2026, 4:00 PM EDT
44.68
+0.17 (0.38%)
After-hours: Oct 21, 2026, 7:59 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Buy" and an average price target of $59.24. The average 1-year stock price forecast is 33.09% higher than the current stock price, while the lowest is $44 (-1.15%) and the highest is $94 (+111.19%).
Price Target: $59.24 (+33.09%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Boston Scientific stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 21 | 20 | 18 | 18 | 17 | 18 |
| Buy | 7 | 7 | 8 | 8 | 8 | 7 |
| Hold | 4 | 4 | 5 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 32 | 31 | 31 | 31 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $57 → $51 | Buy | Maintains | $57 → $51 | +14.58% | Oct 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 | Buy | Maintains | $60 | +34.80% | Oct 14, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $60 → $55 | Buy | Reiterates | $60 → $55 | +23.57% | Oct 13, 2026 |
| BTIG | BTIG | Buy Reiterates $56 | Buy | Reiterates | $56 | +25.81% | Oct 12, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $60 → $55 | Buy | Reiterates | $60 → $55 | +23.57% | Oct 12, 2026 |
Financial Forecast
Revenue This Year
21.16B
from 20.07B
Increased by 5.41%
Revenue Next Year
22.19B
from 21.16B
Increased by 4.85%
EPS This Year
3.24
from 3.06
Increased by 6.03%
EPS Next Year
3.38
from 3.24
Increased by 4.08%
EPS and Forward PE are based on non-GAAP adjusted numbers.